Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-019740
Filing Date
2013-04-02
Accepted
2013-04-02 17:28:57
Documents
1
Period of Report
2013-03-29

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c515456_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c515456_4x0.xml 4 6175
  Complete submission text file 0001209191-13-019740.txt   7510
Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043 650.944.7000
Alexza Pharmaceuticals Inc. (Issuer) CIK: 0001344413 (see all company filings)

EIN.: 770567768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043
Business Address
Cassella James V (Reporting) CIK: 0001353528 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51820 | Film No.: 13736847